Lymphatic absorption is the primary contributor to the systemic availability of epoetin alfa following subcutaneous administration to sheep

Danielle N McLennan, Christopher John H Porter, Glenn A Edwards, Steven W Martin, Anne C Heatherington, Susan A Charman

Research output: Contribution to journalArticleResearchpeer-review

42 Citations (Scopus)
Original languageEnglish
Pages (from-to)345 - 351
Number of pages7
JournalJournal of Pharmacology and Experimental Therapeutics
Volume313
Issue number1
DOIs
Publication statusPublished - 2005

Cite this

@article{ebc53f8c5f8e44b8989665297af07f9f,
title = "Lymphatic absorption is the primary contributor to the systemic availability of epoetin alfa following subcutaneous administration to sheep",
author = "McLennan, {Danielle N} and Porter, {Christopher John H} and Edwards, {Glenn A} and Martin, {Steven W} and Heatherington, {Anne C} and Charman, {Susan A}",
year = "2005",
doi = "10.1124/jpet.104.078790",
language = "English",
volume = "313",
pages = "345 -- 351",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology & Experimental Therapeutics (ASPET)",
number = "1",

}

Lymphatic absorption is the primary contributor to the systemic availability of epoetin alfa following subcutaneous administration to sheep. / McLennan, Danielle N; Porter, Christopher John H; Edwards, Glenn A; Martin, Steven W; Heatherington, Anne C; Charman, Susan A.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 313, No. 1, 2005, p. 345 - 351.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Lymphatic absorption is the primary contributor to the systemic availability of epoetin alfa following subcutaneous administration to sheep

AU - McLennan, Danielle N

AU - Porter, Christopher John H

AU - Edwards, Glenn A

AU - Martin, Steven W

AU - Heatherington, Anne C

AU - Charman, Susan A

PY - 2005

Y1 - 2005

U2 - 10.1124/jpet.104.078790

DO - 10.1124/jpet.104.078790

M3 - Article

VL - 313

SP - 345

EP - 351

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 1

ER -